Impact of changes in viral marker screening assays

Transfusion

Volumn 43, Issue 2, 2003, Pages 202-214

  Sharma, Usha K ^a   Stramer, Susan L ^b   Wright, David J ^b   Glynn, Simone A ^b   Hermansen, Sigurd ^b   Schreiber, George B ^b   Kleinman, Steven H ^b   Busch, Michael P ^b  

^a WESTAT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; SAFETY; SCREENING TEST; SERODIAGNOSIS;

ANTIGENS, VIRAL; BIOLOGICAL MARKERS; BLOOD DONORS; DATA COLLECTION; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; MASS SCREENING; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC;

EID: 0037321722     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00291.x     Document Type: Article

References (35)

1. Busch MP. To thy (reactive) donors be true! Transfusion 1997;37:117-20.
2. McCullough J. The nation's changing blood supply system. JAMA 1993;269:2239-45.
3. Busch MP, Laycock M, Kleinman SH, et al. Accuracy of supplementary testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood 1994;83:1143-8.
4. Busch MP, Kleinman SH, Williams AE, et al. Frequency of human immunodeficiency virus (HIV) infection among contemporary, anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 1996;36:37-44.
5. Kleinman S, Busch MP, Hall L, et al. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study. JAMA 1998;280:1080-5.
6. Kuhnl P, Seidl S, Holzberger G. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results. Lancet 1985;1:1222-3.
7. Simonsen L, Buffington J, Shapiro CN, et al. Multiple false reactions in viral antibody screening assays after influenza vaccination. Am J Epidemiol 1995;141:1089-96.
8. Dow BC. 'Noise' in microbiological screening assays. Transfus Med 2000;10:97-106.
9. Dodd RY, Houlihan K, Lamberson HV. The specificity of enzyme immunoassays for antibodies to HIV: impact on record and donor management. Transfusion 1993;33:693.
10. Jackson JB, Hanson MR, Johnson GM, et al. Long term follow-up of blood donors with indeterminate HIV-1 results on Western blot. Transfusion 1995;35:98-102.
11. Dodd RY. Current viral risks of blood and blood products. Ann Med 2000;32:469-74.
12. Brittenham GM, Klein HG, Kushner JP, Ajioka RS. Preserving the national blood supply. Hematology (Am Soc Hematol Educ Program) 2001;Jan:422-32.
13. Guiltinan AM, Murphy EL, Horton JA, et al. Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus Epidemiology Donor Study. Transfusion 1998;38:1056-62.
14. Wu Y, Schreiber GB, Busch MP, et al. Donor behavior after notification of abnormal laboratory test results (abstract). Transfusion 1999;39(Suppl):113S.
15. Kleinman SH, Williams AE, Busch MP, Wu Y. Donor reactions to notification of abnormal test results (abstract). Transfusion 1999;39(Suppl):113S.
16. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames (IA): Iowa State University Press; 1980:215-20.
17. Kleinman S, Alter H, Busch M, et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992;32:805-13.
18. Comprehensive report on blood collection and transfusion in the United States in 1999. Bethesda: National Blood Data Resource Center; 2001.
19. Sayre KR, Dodd RY, Tegtmeier G, et al. False-positive human immunodeficiency virus type 1 Western blot tests in noninfected blood donors. Transfusion 1996;36:45-52.
20. Dodd RY, Stramer SL. Indeterminate results in blood donor testing: what you don't know can hurt you. Transfus Med Rev 2000;14:151-60.
21. Celum CL, Coombs RW, Jones M, et al. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots: a population-based case-control study. Arch Intern Med 1994;154:1129-37.
22. Dow BC, Munro H, Frame D, Yates P. Several assays show hepatitis B positivity soon after vaccination. BMJ 1998;316:311.
23. Ownby HE, Korelitz JJ, Busch MP, et al. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Retrovirus Epidemiology Donor Study. Transfusion 1997;37:199-205.
24. Busch MP, Lee LL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
25. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-4.
26. Hu DJ, Dondero TJ, Rayfield MA, et al. The emerging genetic diversity of HIV: the importance of global surveillance for diagnosis, research and prevention. JAMA 1996;275:210-6.
27. Dow BC, Follett EA, Davidson F, Calmann M. Comparison of second- and third-generation hepatitis C virus enzymelinked immunosorbent assays in a low-risk blood donor population. Transfusion 1996;36:477-8.
28. Busch MP, Tobler LH, Tegtmeier G, et al. Use of thirdgeneration hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback. Transfusion 2000;40:10-4.
29. Courouce AM, Le Marrec N, Girault A, et al. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 1994;34:790-5.
30. Barrera JM, Francis B, Ercilla G, et al. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 1995;68:15-8.
31. Vrielink H, Zaaijer HL, Reesink HW, et al. Sensitivity and specificity of three third-generation anti-HCV ELISAs. Vox Sang 1995;69:14-7.
32. Vrielink H, Zaaijer HL, Reesink HW, et al. Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assays. Transfusion 1995;35:601-4.
33. Dow BC, Buchanan I, Munro H, et al. Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol 1996;49:132-6.
34. Allain JP. Will genome detection replace serology, in blood screening for microbial agents? Baillieres Best Pract Res Clin Hematol 2000;13:615-29.
35. Sato S, Ohhashi W, Ihara H, et al. Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion 2001;41:1107-13.